172 related articles for article (PubMed ID: 38706892)
1. Butein inhibits oral squamous cell carcinoma growth via promoting MCL-1 ubiquitination.
Wang R; Li X; Wang J
J Cancer; 2024; 15(10):3173-3182. PubMed ID: 38706892
[TBL] [Abstract][Full Text] [Related]
2. Curcumol Exerts Antitumor Effect via Inhibiting EGFR-Akt-Mcl-1 Signaling.
Li XY; Gao F; Wang XC; Liu LL; Gan Y; Han SZ; Zhou L; Li W; Li M
Am J Chin Med; 2023; 51(3):741-760. PubMed ID: 36869017
[TBL] [Abstract][Full Text] [Related]
3. Butein promotes ubiquitination-mediated survivin degradation inhibits tumor growth and overcomes chemoresistance.
Dong X; Liu W; Li X; Gan Y; Zhou L; Li W; Xie L
Sci Rep; 2022 Nov; 12(1):20644. PubMed ID: 36450751
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance.
Li M; Gao F; Li X; Gan Y; Han S; Yu X; Liu H; Li W
Cell Death Dis; 2022 Dec; 13(12):1053. PubMed ID: 36535926
[TBL] [Abstract][Full Text] [Related]
5. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
Maji S; Samal SK; Pattanaik L; Panda S; Quinn BA; Das SK; Sarkar D; Pellecchia M; Fisher PB; Dash R
Oncotarget; 2015 Jun; 6(18):16623-37. PubMed ID: 26009874
[TBL] [Abstract][Full Text] [Related]
6. An Investigation on the Therapeutic Potential of Butein, A Tretrahydroxychalcone Against Human Oral Squamous Cell Carcinoma.
Bordoloi D; Monisha J; Roy NK; Padmavathi G; Banik K; Harsha C; Wang H; Kumar AP; Arfuso F; Kunnumakkara AB
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3437-3446. PubMed ID: 31759370
[TBL] [Abstract][Full Text] [Related]
7. Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization.
Gao F; Yu X; Li M; Zhou L; Liu W; Li W; Liu H
Cell Death Dis; 2020 Feb; 11(2):143. PubMed ID: 32081857
[TBL] [Abstract][Full Text] [Related]
8. Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.
Li M; Gao F; Yu X; Zhao Q; Zhou L; Liu W; Li W
J Exp Clin Cancer Res; 2020 May; 39(1):88. PubMed ID: 32410646
[TBL] [Abstract][Full Text] [Related]
9. Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells.
Gan Y; Li X; Han S; Zhou L; Li W
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259388
[TBL] [Abstract][Full Text] [Related]
10. STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
Maji S; Shriwas O; Samal SK; Priyadarshini M; Rath R; Panda S; Das Majumdar SK; Muduly DK; Dash R
Carcinogenesis; 2019 Mar; 40(1):173-183. PubMed ID: 30395230
[TBL] [Abstract][Full Text] [Related]
11. Promotive effects of HOXA10 antisense RNA on the stemness of oral squamous cell carcinoma stem cells through a microRNA-29a/MCL-1/phosphatidyl inositol 3-kinase/protein kinase B axis.
Wang D
Arch Oral Biol; 2021 Jun; 126():105114. PubMed ID: 33831733
[TBL] [Abstract][Full Text] [Related]
12. Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells.
Palve VC; Teni TR
Radiat Oncol; 2012 Aug; 7():135. PubMed ID: 22873792
[TBL] [Abstract][Full Text] [Related]
13. Elevated USP9X drives early-to-late-stage oral tumorigenesis via stabilisation of anti-apoptotic MCL-1 protein and impacts outcome in oral cancers.
Sulkshane P; Pawar SN; Waghole R; Pawar SS; Rajput P; Uthale A; Oak S; Kalkar P; Wani H; Patil R; Nair S; Rane P; Teni T
Br J Cancer; 2021 Aug; 125(4):547-560. PubMed ID: 34079080
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.
Li M; Gao F; Zhao Q; Zuo H; Liu W; Li W
Cell Death Dis; 2020 May; 11(5):381. PubMed ID: 32424132
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
[TBL] [Abstract][Full Text] [Related]
16. Mithramycin A inhibits myeloid cell leukemia-1 to induce apoptosis in oral squamous cell carcinomas and tumor xenograft through activation of Bax and oligomerization.
Shin JA; Jung JY; Ryu MH; Safe S; Cho SD
Mol Pharmacol; 2013 Jan; 83(1):33-41. PubMed ID: 23019217
[TBL] [Abstract][Full Text] [Related]
17. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.
Zhang G; Zhao X; Liu W
Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy.
Kim MJ; Chen G; Sica GL; Deng X
Cancer Biol Ther; 2021 Jan; 22(1):55-65. PubMed ID: 33336620
[TBL] [Abstract][Full Text] [Related]
19. Butein activates p53 in hepatocellular carcinoma cells via blocking MDM2-mediated ubiquitination.
Zhou Y; Wang K; Zhou N; Huang T; Zhu J; Li J
Onco Targets Ther; 2018; 11():2007-2015. PubMed ID: 29670376
[TBL] [Abstract][Full Text] [Related]
20. Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer.
Yu X; Gao F; Li W; Zhou L; Liu W; Li M
J Exp Clin Cancer Res; 2020 Apr; 39(1):62. PubMed ID: 32276600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
